Lars Bullinger
- Hematology top 0.05%
- Acute Myeloid Leukemia Research 160
- Chronic Myeloid Leukemia Treatments 38
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 42
- Chronic Lymphocytic Leukemia Research 33
- Pathology and Forensic Medicine top 0.1%
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 27
- Immunology top 0.5%
-
- Protein Degradation and Inhibitors 37
- Epigenetics and DNA Methylation 31
- Histone Deacetylase Inhibitors Research 22
- Co-authors
- Hartmut DöhnerKonstanze DöhnerStephan StilgenbauerAxel BennerRichard F. SchlenkPeter LichterAlexander KröberStefan Fröhling
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Lars Bullinger
302 papers receiving 16.4k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Hematology 7.7k
- Genetics 5.8k
- Pathology and Forensic Medicine 3.3k
- Cancer Research 2.7k
- Immunology 3.0k
Countries citing papers authored by Lars Bullinger
This map shows the geographic impact of Lars Bullinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bullinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bullinger more than expected).
Fields of papers citing papers by Lars Bullinger
This network shows the impact of papers produced by Lars Bullinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bullinger. The network helps show where Lars Bullinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lars Bullinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 6 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 22 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 42 | |
| 10 | 2022 | 34 | |
| 11 | 2020 | 152 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 1 | |
| 14 | 2020 | 12 | |
| 15 | Genomics of Acute Myeloid Leukemia Diagnosis and Pathwaysbreakdown → | 2017 | 331 |
| 16 | 2017 | 23 | |
| 17 | 2017 | 19 | |
| 18 | 2013 | 31 | |
| 19 | 2011 | 37 | |
| 20 | 2010 | 262 |
About Lars Bullinger
Lars Bullinger is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Oncology, having authored 321 papers that have together received 16.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (160 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (42 papers), Chronic Myeloid Leukemia Treatments (38 papers), Protein Degradation and Inhibitors (37 papers), Chronic Lymphocytic Leukemia Research (33 papers), Epigenetics and DNA Methylation (31 papers), Cancer Genomics and Diagnostics (27 papers) and Histone Deacetylase Inhibitors Research (22 papers). The work is most often cited by research in Hematology (7.7k citations), Genetics (5.8k citations), Pathology and Forensic Medicine (3.3k citations), Cancer Research (2.7k citations) and Immunology (3.0k citations). Lars Bullinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hartmut Döhner, Konstanze Döhner, Stephan Stilgenbauer, Axel Benner, Richard F. Schlenk, Peter Lichter, Alexander Kröber, Stefan Fröhling, Martin Bentz and Elke Leupolt. Their work appears in journals such as Blood, Leukemia, Haematologica, Journal of Clinical Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.